Susquehanna International Group’s BioAtla BCAB Stock Holding History

Susquehanna International Group’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-394	Closed	-$67.8K	–	12035
2024 Q1	$67.8K	Buy	+394	New	+$49K	﹤0.01%	11427
2023 Q4	–	Sell	-980	Closed	-$83.3K	–	12334
2023 Q3	$83.3K	Buy	+980	New	+$125K	﹤0.01%	11048
2023 Q2	–	Sell	-446	Closed	-$59.8K	–	12056
2023 Q1	$59.8K	Sell	446 -136	-23%	-$24.5K	﹤0.01%	11613
2022 Q4	$240K	Sell	582 -1,690	-74%	-$701K	﹤0.01%	9668
2022 Q3	$875K	Buy	+2,272	New	+$744K	﹤0.01%	6983
2022 Q2	–	Sell	-1,142	Closed	-$286K	–	12873
2022 Q1	$286K	Buy	+1,142	New	+$478K	﹤0.01%	10385

Other funds holding BCAB

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's BCAB Position: Q1 2026 in Review

Susquehanna International Group reduced its BioAtla (BCAB) stake by 52% in Q1 2026, selling an estimated $9.98K and leaving 781 shares worth $6.29K. The position accounts for ﹤0.01% of the portfolio, ranked #12969.

Susquehanna International Group first reported a position in BCAB in Q2 2021 and has held it in 20 quarters since. The position peaked at $1.88M in Q4 2022. 36 funds tracked by Wall St. Rank hold BCAB as of Q1 2026.

Susquehanna International Group held 781 shares of BioAtla worth $6.29K as of Q1 2026.
Susquehanna International Group sold 853 BioAtla shares in Q1 2026, an estimated $9.98K.
BioAtla made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12969 holding.
Susquehanna International Group first reported a position in BioAtla in Q2 2021 and has held it in 20 quarters since.
Susquehanna International Group's BioAtla position peaked at $1.88M in Q4 2022.
36 funds tracked by Wall St. Rank held BioAtla as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.